Attached files
| file | filename |
|---|---|
| S-1MEF - S-1MEF - Oric Pharmaceuticals, Inc. | d69541ds1mef.htm |
| EX-5.1 - EX-5.1 - Oric Pharmaceuticals, Inc. | d69541dex51.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
ORIC Pharmaceuticals, Inc.:
We consent to the use of our report dated February 28, 2020, except as to note 11, which is as of April 21, 2020, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
November 12, 2020